Why do pharmaceuticals cost so much?
11 apr 2020 ·
16 min. 5 sec.
Iscriviti gratuitamente
Ascolta questo episodio e molti altri. Goditi i migliori podcast su Spreaker!
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
In this discussion, Andrew Satz, CEO and Daniel Gigante chat about the cost of pharmaceuticals. Andrew begins by detailing the major input required to not just bring a drug to...
mostra di più
In this discussion, Andrew Satz, CEO and Daniel Gigante chat about the cost of pharmaceuticals. Andrew begins by detailing the major input required to not just bring a drug to market, but to protect it legislatively. He then covers how AI (read: EVQLV) can potentially reduce the cost of drug discovery.
With respect to EVQLV, Andrew feels the company can't eliminate any variables that factor into cost, but instead can mitigate the damage from specific variables.
Music: www.bensound.com/
For more information on EVQLV, check out our site here: www.evqlv.com/
mostra meno
With respect to EVQLV, Andrew feels the company can't eliminate any variables that factor into cost, but instead can mitigate the damage from specific variables.
Music: www.bensound.com/
For more information on EVQLV, check out our site here: www.evqlv.com/
Informazioni
| Autore | Daniel Gigante |
| Organizzazione | Daniel Gigante |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
